28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250728212094/en/MAIA-Biotechnology-Receives-FDAs-Fast-Track-Designation-for-Ateganosine-as-a-Treatment-for-Non-Small-Cell-Lung-Cancer
01 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250401656979/en/MAIA-Biotechnology-CEO-Details-Anticipated-Clinical-Milestones-for-Novel-Cancer-Immunotherapy-in-2025-Letter-to-Shareholders